GTX vs. NAGE
GTX (Garrett Motion Inc.) and NAGE (Niagen Bioscience, Inc) are both stocks. GTX operates in Auto Parts (Consumer Cyclical), while NAGE operates in Biotechnology (Healthcare). Over the past 5 years, GTX returned 37.74%/yr vs -17.11%/yr for NAGE. Their 0.14 correlation means their historical movements had little consistent relationship.
Performance
GTX vs. NAGE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GTX achieves a 79.86% return, which is significantly higher than NAGE's -46.54% return.
GTX
- 1D
- 0.45%
- 1M
- -1.89%
- 6M
- 73.78%
- YTD
- 79.86%
- 1Y
- 145.52%
- 3Y*
- 59.53%
- 5Y*
- 37.74%
- 10Y*
- —
- ALL TIME*
- 4.89%
NAGE
- 1D
- 2.41%
- 1M
- -0.87%
- 6M
- -43.24%
- YTD
- -46.54%
- 1Y
- -62.39%
- 3Y*
- 25.75%
- 5Y*
- -17.11%
- 10Y*
- -1.18%
- ALL TIME*
- -5.25%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $74.68M | $73.43M | $92.59M | |
| $2.07M | $2.33M | $3.13M |
GTX vs. NAGE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
GTX Garrett Motion Inc. | 79.86% | 97.23% | -6.62% | 26.90% | -5.11% | 81.26% | -55.66% | -19.04% | -43.91% |
NAGE Niagen Bioscience, Inc | -46.54% | 19.89% | 270.98% | -14.88% | -55.08% | -22.08% | 11.37% | 25.66% | -12.05% |
Correlation
The correlation between GTX and NAGE is 0.23, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.23 |
Correlation (3Y) Balances recent behavior with more history. | 0.17 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.19 |
Correlation (All Time) Calculated using the full available price history since Sep 17, 2018 | 0.14 |
Fundamentals
GTX:
$5.81B
NAGE:
$270.79M
GTX:
$1.82
NAGE:
$0.22
GTX:
17.09
NAGE:
15.55
GTX:
0.14
NAGE:
0.13
GTX:
1.63
NAGE:
2.22
GTX:
$3.75B
NAGE:
$130.42M
GTX:
$881.00M
NAGE:
$83.83M
GTX:
$482.00M
NAGE:
$13.37M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GTX vs. NAGE — Risk / Return Rank
GTX
NAGE
GTX vs. NAGE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Garrett Motion Inc. (GTX) and Niagen Bioscience, Inc (NAGE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GTX | NAGE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.21 | ||
| Sortino ratioReturn per unit of downside risk | +6.71 | ||
| Omega ratioGain probability vs. loss probability | 1.54 | 0.74 | +0.80 |
| Calmar ratioReturn relative to maximum drawdown | 6.98 | -0.93 | +7.91 |
| Martin ratioReturn relative to average drawdown | 19.97 | -1.38 | +21.35 |
Loading charts...
Drawdowns
GTX vs. NAGE - Drawdown Comparison
The maximum GTX drawdown since its inception was -93.91%, roughly equal to the maximum NAGE drawdown of -97.00%. Use the drawdown chart below to compare losses from any high point for GTX and NAGE.
Loading charts...
Drawdown Indicators
| GTX | NAGE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.91% | -97.00% | +3.09% |
Max Drawdown (1Y)Largest decline over 1 year | -20.56% | -68.91% | +48.35% |
Max Drawdown (3Y)Largest decline over 3 years | -26.82% | -77.86% | +51.04% |
Max Drawdown (5Y)Largest decline over 5 years | -31.49% | -86.58% | +55.09% |
Max Drawdown (10Y)Largest decline over 10 years | — | -93.65% | — |
Current DrawdownCurrent decline from peak | -14.02% | -81.86% | +67.84% |
Average DrawdownAverage peak-to-trough decline | -55.52% | -75.76% | +20.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.19% | 46.13% | -38.94% |
Volatility
GTX vs. NAGE - Volatility Comparison
The current volatility for Garrett Motion Inc. (GTX) is 13.44%, while Niagen Bioscience, Inc (NAGE) has a volatility of 14.85%. This indicates that GTX experiences smaller price fluctuations and is considered to be less risky than NAGE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GTX | NAGE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.44% | 14.85% | -1.41% |
Volatility (6M)Calculated over the trailing 6-month period | 38.03% | 36.77% | +1.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.35% | 49.10% | +0.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 41.63% | 76.59% | -34.96% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 63.83% | 78.49% | -14.66% |
Dividends
GTX vs. NAGE - Dividend Comparison
GTX's dividend yield for the trailing twelve months is around 0.96%, while NAGE has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
GTX Garrett Motion Inc. | 0.96% | 1.49% |
NAGE Niagen Bioscience, Inc | 0.00% | 0.00% |
Financials
GTX vs. NAGE - Financials Comparison
This section allows you to compare key financial metrics between Garrett Motion Inc. and Niagen Bioscience, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GTX vs. NAGE - Profitability Comparison
GTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Garrett Motion Inc. reported a gross profit of 212.00M and revenue of 976.00M. Therefore, the gross margin over that period was 21.7%.
NAGE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Niagen Bioscience, Inc reported a gross profit of 19.98M and revenue of 31.47M. Therefore, the gross margin over that period was 63.5%.
GTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Garrett Motion Inc. reported an operating income of -2.00M and revenue of 976.00M, resulting in an operating margin of -0.2%.
NAGE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Niagen Bioscience, Inc reported an operating income of 1.58M and revenue of 31.47M, resulting in an operating margin of 5.0%.
GTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Garrett Motion Inc. reported a net income of 101.00M and revenue of 976.00M, resulting in a net margin of 10.4%.
NAGE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Niagen Bioscience, Inc reported a net income of 6.32M and revenue of 31.47M, resulting in a net margin of 20.1%.
Frequently Asked Questions
GTX and NAGE have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NAGE has higher volatility (14.85%) compared to GTX (13.44%). In terms of maximum drawdown, GTX dropped -93.91% vs NAGE's -97.00%.
GTX currently has the higher Sharpe Ratio (2.91 vs -1.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GTX and NAGE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer